In the double transgenic APP/PS1 model of amyloidosis, increased levels of CCL3 and CCL4 were found in the brain within a frame of 7 to 15 months of age (Jorda et al. 2019; Martin et al. 2019; Zhu et al. 2014). The gene discussed is APP; the disease is amyloidosis.